CMA Issues £70m Fines To Pfizer And Flynn Over Phenytoin

UK Regulator Finds Firms Abused Dominant Position To Overcharge NHS

 
• By Dave Wallace
  
CMA
The CMA has reassessed part of the case

More from Legal & IP

More from Generics Bulletin